Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
On the importance of being powerful to detecting specific regulations in omics studies.
Journal: Nature plants
Published: May 04, 2026
Enhancement of Arabidopsis Growth by Enterobacter sp. SA187 Under Elevated CO2 Is Dependent on Ethylene Signalling Activation and Primary Metabolism Reprogramming.
Journal: Plant, cell & environment
Published: January 27, 2026
Enterobacter sp. SA187 boosts high-affinity nitrate transporters expression, ethylene signaling, and plant growth under low nitrate.
Journal: The New phytologist
Published: July 03, 2025
A Functional Photorespiratory Cycle Is Essential for Light-Dependent Stomata Opening in Epidermal Peels of Arabidopsis thaliana.
Journal: Physiologia plantarum
Published: May 27, 2025
Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 16, 2024
A phase 1 open label study to assess the human mass balance and metabolite profile of 14C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants.
Journal: Antimicrobial agents and chemotherapy
Published: July 16, 2024
Determination of Phosphoglycolate Phosphatase Activity via a Coupled Reaction Using Recombinant Glycolate Oxidase.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 11, 2024
Purification of Recombinant N-terminal Histidine-Tagged Arabidopsis thaliana Phosphoglycolate Phosphatase 1, Glycolate Oxidase 1 and 2, and Hydroxypyruvate Reductase 1.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 11, 2024
Measuring Phosphoglycolate Phosphatase Activity Using NMR Detection of Glycolate.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 11, 2024
Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: May 17, 2024
Nonclinical and clinical characterization of MAU868, a novel human-derived monoclonal neutralizing antibody targeting BK polyomavirus VP1.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 15, 2024
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants.
Journal: Antimicrobial agents and chemotherapy
Published: March 29, 2024
Last Updated: 09/26/2026